CFH rs1061177: Understanding This Genetic Variant and Eye Health
The rs1061177 variant is a common genetic change located within the CFH gene, which plays a critical role in regulating the body's immune response. Research has identified this variant as part of a haplotype associated with susceptibility to age-related macular degeneration (AMD).
What each genotype means
Protective haplotype carrier
This genotype is associated with a protective haplotype in the complement factor H gene that may reduce vulnerability to age-related macular degeneration. Research suggests this variant tags a genetic background that supports normal regulation of the complement system in the eye.
This genotype is common, appearing in approximately 35-45% of European and Asian populations.
Intermediate risk profile
Carrying one copy of each allele represents a heterozygous state for this synonymous variant. While this variant is often studied as part of a larger protective haplotype, its individual contribution to eye health remains limited and is not considered a diagnostic indicator for macular degeneration.
This genotype is common, appearing in approximately 35-45% of European and Asian populations.
Baseline genetic profile
This genotype represents the alternative state for this specific synonymous variant. Current evidence does not suggest that this genotype alone significantly alters the function of the complement factor H protein or confers a high risk for eye-related conditions.
This genotype is common, appearing in approximately 35-45% of European and Asian populations.
What is rs1061177?
The rs1061177 variant is a single-nucleotide polymorphism (SNP) found within the CFH gene, which is located on chromosome 1. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is classified as a synonymous change, meaning that while the DNA sequence is altered, it does not change the amino acid sequence of the resulting protein. Instead, rs1061177 often serves as a genetic tag. Because it is frequently inherited alongside other nearby variants, it acts as a marker for a specific haplotype—a group of genes or DNA variations that are inherited together from a single parent. By studying this tag, researchers can better understand the genetic architecture of the CFH region and its influence on biological processes.
The Role of the CFH Gene
The CFH gene provides the instructions for creating complement factor H, a vital protein in the human immune system. This protein acts as a primary regulator of the alternative complement pathway, a part of the innate immune system that helps the body defend against pathogens. By controlling this pathway, complement factor H prevents the immune system from accidentally damaging the body's own healthy tissues. In the eye, this protein is synthesized by the retinal pigmented epithelium and is found within drusen, which are small yellow deposits that accumulate under the retina. When the regulation of the complement pathway is disrupted, it can lead to chronic inflammation, which is a hallmark of various conditions, including age-related macular degeneration (AMD).
Research and Evidence Strength
The association between the CFH gene and AMD is well-documented in scientific literature. Multiple studies have identified that variations in this gene can significantly influence an individual's risk of developing the condition. While rs1061177 is recognized as a marker for a protective haplotype, the evidence regarding its individual functional impact is considered limited compared to other well-studied missense variants in the same gene, such as Y402H. Most research focuses on how these haplotypes modulate the complement system's activity. It is important to note that genetic risk is only one piece of the puzzle; AMD is a complex, multifactorial disease influenced by a combination of genetics, environmental factors, and aging. Current evidence suggests that while this variant is statistically associated with disease risk, it does not act as a definitive diagnostic tool.
Population Frequency
The rs1061177 variant is relatively common across various global populations. It is frequently observed in both European and Asian cohorts, with reported frequencies typically ranging between 35% and 45%. Because it is a common variant, it is present in a large portion of the general population, which is why researchers use it to study broad trends in genetic susceptibility. However, the distribution of associated haplotypes can vary significantly between different ancestral groups. Understanding these frequency differences is essential for researchers conducting large-scale genomic studies, as it helps them account for population-specific genetic backgrounds when analyzing the link between the CFH gene and eye health outcomes.
What This Information Means for You
Learning about genetic variants like rs1061177 can be an educational way to understand the biological factors that contribute to eye health. However, it is crucial to recognize that this information is for informational purposes only and should not be used for medical diagnosis or to predict personal health outcomes. Genetic associations are statistical observations made across large groups of people and do not necessarily apply to any single individual. If you have concerns about your vision or a family history of macular degeneration, the most effective step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can provide personalized screenings and discuss evidence-based strategies for maintaining eye health as you age.
How common is this variant?
The rs1061177 variant is common in European and Asian populations, with allele frequencies typically observed between 35% and 45%.
Frequently asked questions
Is rs1061177 a diagnostic test for AMD?
No, rs1061177 is not a diagnostic test. While it is associated with the risk of developing age-related macular degeneration, it is only one of many genetic and environmental factors that contribute to the disease.
Can I change my risk if I have this variant?
Genetic variants are inherited and cannot be changed. However, you can discuss lifestyle factors, such as diet, smoking cessation, and regular eye exams, with your doctor to support your overall eye health.
What does 'synonymous variant' mean?
A synonymous variant is a change in the DNA sequence that does not alter the amino acid sequence of the protein produced by the gene. It is often referred to as a 'silent' mutation because the protein's structure remains the same.
Where can I find more information on CFH and eye health?
You can explore resources like MedlinePlus Genetics or the National Eye Institute website for reliable, research-backed information on the CFH gene and its role in age-related macular degeneration.
Sources & further reading
Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1061177?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFH
This variant in the complement factor H gene is associated with altered regulation of the alternative complement pathway and increased susceptibility to age-related macular degeneration.
This regulatory variant in the CFH locus is linked to complement system dysregulation and is a recognized genetic risk factor for age-related macular degeneration.
Intronic single nucleotide variant in the CFH region associated with susceptibility to age-related macular degeneration (AMD).
Common variant in the CFH locus strongly associated with risk of age-related macular degeneration (AMD).
Genomic marker in CFH frequently co-inherited in haplotypes modulating risk of late-stage visual loss from macular degeneration.
Intronic marker in CFH forming critical susceptibility haplotypes for choroidal neovascularization and macular atrophy.